Qiang Li

机构：Central South University, Capital Medical University, Third People's Hospital of Chengdu, Second Hospital of Shandong University, Institute of Forensic Science, Second Xiangya Hospital of Central South University, Second Affiliated Hospital of Shandong University of TCM · ORCID：0000-0003-3610-6934

发表论文 138 篇 · 总被引 2589 次 · h-index 26

代表论文

• UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier (2024 · Advanced Science · 被引 15)
• Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein (2024 · Phytomedicine · 被引 13)
• Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial. (2023 · Journal of Clinical Oncology · 被引 13)
• Acceleration of bone repairation by BMSCs overexpressing NGF combined with NSA and allograft bone scaffolds (2024 · Stem Cell Research & Therapy · 被引 9)
• Sevoflurane promotes neuronal ferroptosis via upregulation of PLIN4 to modulate the hippo signaling pathway (2024 · NeuroToxicology · 被引 8)
• Traditional Chinese Medicine Properties and Microcalorimetry: BioScience Evaluation (2025 · Med Research · 被引 7)